Verastem, Inc. (VSTM)
4.15
-0.11
(-2.58%)
USD |
NASDAQ |
May 19, 16:00
4.15
0.00 (0.00%)
After-Hours: 18:44
Verastem Research and Development Expense (Quarterly) : 38.22M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Altimmune, Inc. | 16.17M |
| Ocugen, Inc. | 11.26M |
| BioXcel Therapeutics, Inc. | 2.792M |
| Xilio Therapeutics, Inc. | 19.83M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |